Articles
Patheon Inc. Extends Its Sterile Filling Capabilities To Include The Commercial Supply Of Small Scale Specialty Products
June 11, 2009
Patheon Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry, is pleased to announce that its Swindon, UK facility has extended its aseptic vial filling capabilities to include the commercial supply of small scale specialty products. Following recent FDA approval at Swindon, Patheon can now provide clients with a seamless service, where development batches and commercial product can be supplied from the same filling line.
The offering will be especially suited to commercial supply of niche biological and orphan drug products where the annual volumes are small. This new capability is now operating at Patheon's Swindon site for vial sizes ranging from 2mL up to 30mL. In addition, the new technology allows the use of disposable components in place of more costly stainless steel vessels. This provides clients with an efficient filling process that overcomes challenges posed by many large and small molecule sterile products.
Wes Wheeler, President and CEO of Patheon Inc. stated, "We can now produce commercial product from the same production line that is used for Phase II and Phase III clinical batches. This allows clients to commercialize their drugs much faster than would normally be expected."
About Patheon Inc.
Patheon Inc. is a leading global provider of contract development and manufacturing services to the pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through the commercial manufacturing of a wide array of dosage forms including parenteral, solid, semi-solid and liquids. Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon's ability to integrate development and manufacturing services ensures that our customers' projects are delivered on time and meet the high standards of quality that Patheon is known for. Patheon's integrated development and manufacturing network of 10 facilities and 7 development centers, across North America and Europe, strives to ensure that customer products can be launched timely and confidently anywhere in the world. For more information visit www.patheon.com
SOURCE: Patheon Inc.
